Article Details

AVROBIO, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for ...

Retrieved on: 2018-01-31 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

AVROBIO, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for .... View article details on hiswai:

Excerpt

<div>The Series B round was co-led by Cormorant Asset Management and Surveyor Capital (a Citadel company), and included participation by Aisling, Brace Pharma Capital, Eventide Asset Management and Morningside, along with existing investors <b>Atlas Venture</b>, SV Health Investors and Clarus Ventures.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up